Third annual JBC Methods Madness tournament
Calling all scientists! The Journal of Biological Chemistry’s third annual Methods Madness tournament is finally here.
Last year’s tournament stirred up quite the rivalry, with #TeamMassSpec dethroning #TeamCryo as the #JBCMethodsMadness champion! This year we welcome new contenders, including #TeamFlow, #TeamMedicine and #TeamProtein. Will one of these newbies make it to the finals? You decide!
The madness begins on Monday, March 7. (See tournament schedule below.) Submit your bracket by Sunday, March 6, for a chance to win a $100 gift card.
Round 1: The Scientific 16
Vote for your favorite methods by participating in polls posted by .
Monday, March 7
9 a.m. – #TeamMassSpec vs. #TeamNMR
2 p.m. – #TeamXRC vs. #TeamImmuno
Tuesday, March 8
9 a.m. – #TeamChroma vs. #TeamFRET
2 p.m. – #TeamFlow vs. #TeamPCR
Wednesday, March 9
9 a.m. – #TeamCRISPR vs. #TeamOmics
2 p.m. – #TeamSuperRes vs. #TeamOpto
Thursday, March 10
9 a.m. – #TeamCryo vs. #TeamMedicine
2 p.m. – #TeamLiveCell vs. #TeamProtein
All times Eastern.
Enjoy reading ASBMB Today?
Become a member to receive the print edition four times a year and the digital edition monthly.
Learn moreGet the latest from ASBMB Today
Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.
Latest in Science
Science highlights or most popular articles

How scientists identified a new neuromuscular disease
NIH researchers discover Morimoto–Ryu–Malicdan syndrome, after finding shared symptoms and RFC4 gene variants in nine patients, offering hope for faster diagnosis and future treatments.

Unraveling cancer’s spaghetti proteins
MOSAIC scholar Katie Dunleavy investigates how Aurora kinase A shields oncogene c-MYC from degradation, using cutting-edge techniques to uncover new strategies targeting “undruggable” molecules.

How HCMV hijacks host cells — and beyond
Ileana Cristea, an ASBMB Breakthroughs webinar speaker, presented her research on how viruses reprogram cell structure and metabolism to enhance infection and how these mechanisms might link viral infections to cancer and other diseases.

Understanding the lipid link to gene expression in the nucleus
Ray Blind, an ASBMB Breakthroughs speaker, presented his research on how lipids and sugars in the cell nucleus are involved in signaling and gene expression and how these pathways could be targeted to identify therapeutics for diseases like cancer.

Receptor antagonist reduces age-related bone loss in mice
Receptor antagonist reduces bone loss and promotes osteoblast activity in aging mice, highlighting its potential to treat osteoporosis. Read more about this recent JBC paper.

Engineered fusion protein targets kiwifruit pathogen
Synthetic protein selectively kills kiwifruit pathogen, offering a promising biocontrol strategy for agriculture. Read more about this recent JBC paper.